Warning: This security is no longer trading.
Company is now merged with Alpine Immune Sciences and trades under the symbol ALPN
Nivalis Therapeutics, Inc. (NVLS): Price and Financial Metrics
Today's Latest Price: $2.40 USD
Jul 24 7:06pm Add NVLS to Watchlist Sign Up POWR Components:
Buy & Hold Grade
Peer Grade Industry Rank NVLS Price/Volume Stats
37.58M Nivalis Therapeutics, Inc. (NVLS) Company Bio
Nivalis Therapeutics is a clinical stage pharmaceutical company committed to the discovery, development and commercialization of small molecule therapeutics for patients with cystic fibrosis. The company was founded in 2007 and is based in Boulder, Colorado.
NVLS Latest News Stream
All News Types Commentary Corp. News Downgrade Earnings Insider Buying Job Cuts M&A New Coverage (Bullish) Product News Rating Reiterated (Bullish) Rating Reiterated (Neutral)
Event/Time News Detail Loading, please wait...
NVLS Price Returns
N/A Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.8952 seconds.